Theories and clinical applications of biochemotherapy for malignant carcinomas
10.3969/j.issn.1000-8179.2016.23.680
- VernacularTitle:恶性肿瘤生物化疗的原理与临床应用
- Author:
Qing LV
;
Zhengyun ZOU
- Keywords:
biochemotherapy;
tumor;
adaptive cell-transfer therapy;
monoclonal antibody;
immunomodulator;
tumor vaccine
- From:
Chinese Journal of Clinical Oncology
2016;43(23):1061-1066
- CountryChina
- Language:Chinese
-
Abstract:
Chemoimmunotherapy or biochemotherapy, the combination of chemotherapy with immunotherapy, is a novel compre-hensive treatment model for malignant carcinoma. In recent years, many clinical trials have shown that biochemotherapy is associated with an improved response rate. Such biological agents include tumor vaccines, monoclonal antibodies, cytokines, and immunocompe-tent cells. In this article, we review the theories, sort the clinical applications of novel treatments, and discuss some of the problems existing in this field.
